Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
641.00    -4.00 (-0.62%)
Bid:
638.00
Ask:
640.00
Spread: 2.00 (0.313%)
Market Cap: £521.75m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

12 Aug 2025 16:29

RNS Number : 0489V
Bloomsbury Publishing PLC
12 August 2025
 

12 August 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

Sale of shares following the vesting and exercise of options under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

 

The Company announced on 11 August 2025 that the conditional share award granted in August 2022 under the 2014 PSP vested at 87% of the maximum on 10 August 2025.

Nigel Newton, Chief Executive and PDMR, acquired 112,472 ordinary shares of 1.25 pence in the Company ("Ordinary Shares") (comprising 103,492 vested 2014 PSP shares and 8,980 dividend equivalent shares, both for nil consideration). Penny Scott-Bayfield, Group Finance Director and PDMR, acquired 70,252 Ordinary Shares (comprising 64,643 vested 2014 PSP shares and 5,609 dividend equivalent shares, both for nil consideration).

On 12 August 2025, Mr Newton and Ms Scott-Bayfield sold 50,867 and 33,185 Ordinary Shares respectively at a share price of £4.764739 per share in order to fund the tax liabilities and administrative fees arising on vesting. Mr Newton and Ms Scott-Bayfield retained the balance of 61,605 and 37,067 Ordinary Shares respectively.

Following these transactions, the shareholdings of Mr Newton and Ms Scott-Bayfield's (including persons closely associated) in the Company are as follows:

PDMR

 

Total shareholding in the Company

Percentage of the Company's issued share capital

Nigel Newton

1,690,596 Ordinary Shares

2.07%

Penny Scott-Bayfield

260,442 Ordinary Shares

0.32%

 

This vesting was satisfied through the transfer of shares from the Bloomsbury Employee Benefit Trust.

 

Notifications

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

50,867

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

33,185

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDIRDBDGUD
Date   Source Headline
21st Apr 20208:45 amRNSTotal Voting Rights
20th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 202011:50 amRNSResult of Placing
17th Apr 20207:00 amRNSTrading and Dividend Update & Equity Placing
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 20204:42 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSBloomsbury Acquires Zed Books' Assets
19th Mar 20207:00 amRNSPre-close Trading Update
5th Feb 20205:39 pmRNSDirector Declaration
10th Dec 201910:45 amRNSBloomsbury Acquires Oberon Books
2nd Dec 20197:00 amRNSBLOOMSBURY ENTERS DOMESTIC CHINESE MARKET
25th Nov 20195:15 pmRNSBlock Listing Six Monthly Return
29th Oct 20197:00 amRNSUnaudited Interim Results
21st Oct 20196:18 pmRNSHolding(s) in Company
16th Oct 20195:58 pmRNSHolding(s) in Company
12th Sep 20195:29 pmRNSHolding(s) in Company
5th Sep 20193:37 pmRNSHolding(s) in Company
22nd Aug 20197:00 amRNSDirector/PDMR Shareholding
17th Jul 20194:19 pmRNSResults of the 2019 Annual General Meeting
17th Jul 20197:00 amRNSTrading Update
18th Jun 20198:21 amRNSAnnual Financial Report
7th Jun 201911:34 amRNSHolding(s) in Company
7th Jun 20197:00 amRNSHolding(s) in Company
31st May 20193:11 pmRNSDirector/PDMR Shareholding
24th May 20193:21 pmRNSBlock listing Interim Review
23rd May 201912:30 pmRNSDirector/PDMR Shareholding
22nd May 20198:09 amRNSDividend Declaration
21st May 201912:47 pmRNSBoard Appointment
21st May 20197:00 amRNSAudited Preliminary Results
14th May 20193:19 pmRNSDirector/PDMR Shareholding
2nd May 20191:30 pmRNSHolding(s) in Company
4th Apr 20194:28 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSBloomsbury Publishing Plc - Trading Update
7th Jan 20197:00 amRNSBloomsbury Announces Two Digital Partnerships
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
20th Nov 20183:36 pmRNSBlock Listing Six Monthly Return
8th Nov 20189:00 amRNSBloomsbury's Sarah J. Maas tops bestseller lists
23rd Oct 20187:05 amRNSICAEW partners with Bloomsbury Professional
23rd Oct 20187:00 amRNSBloomsbury Interim Results
19th Sep 20187:00 amRNSBloomsbury to publish Authorised History of GCHQ
18th Sep 20185:29 pmRNSDirector/PDMR Shareholding
31st Jul 20185:25 pmRNSDirector/PDMR Shareholding
18th Jul 20183:00 pmRNSResult of AGM
18th Jul 20187:01 amRNSBloomsbury Partnership with YOOX NET-A-PORTER
18th Jul 20187:00 amRNSTrading Update
9th Jul 20187:00 amRNSBloomsbury Author Wins The Golden Man Booker Prize
6th Jul 20186:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.